Mackenzie Financial
CLBT icon

Mackenzie Financial’s Cellebrite CLBT Stock Holding History

Mackenzie Financial’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52,860
Closed -$846K – 1729
2025
Q2 		$846K Buy
+52,860
New +$942K ﹤0.01% 1061
2025
Q1 		– Sell
-35,217
Closed -$776K – 1702
2024
Q4 		$776K Buy
+35,217
New +$678K ﹤0.01% 1010
2024
Q2 		– Sell
-15,435
Closed -$171K – 1556
2024
Q1 		$171K Buy
+15,435
New +$158K ﹤0.01% 1368

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Mackenzie Financial's CLBT Position: Q3 2025 in Review

Mackenzie Financial sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 52,860 shares — an estimated $846K sold.

Mackenzie Financial first reported a position in CLBT in Q1 2024 and held it in 3 quarters. The position peaked at $846K in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Mackenzie Financial reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Mackenzie Financial sold 52,860 Cellebrite shares in Q3 2025, an estimated $846K.
  • Mackenzie Financial first reported a position in Cellebrite in Q1 2024 and held it in 3 quarters.
  • Mackenzie Financial's Cellebrite position peaked at $846K in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.